WH
Whitehawk Therapeutics Inc
WHWK · NASDAQ
$4.04 -3.81% (-$0.16)
1M -17.21%
Market Cap $230.3M
P/E Ratio -
Div. Yield -
ROE 53.89%
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 1.26x
P/FCF N/A
P/FFO N/A
Growth
0 /100
Declining Book val. growth 4.88%
Rev. growth 22.27%
FCF growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROA 41.15%
ROIC 47.05%
Debt
100 /100
Low Current ratio 17.38x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
38 /100
Moderate Profitable years 0
EPS volatility 46.13%
Beta 0.81x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o WHWK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David J. Lennon
Employees
32
Headquarters
Morristown
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report